Lista de obras - Jose Manuel Lozano - Dominio Público Uruguay

A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria.

artículo científico publicado en 2017

A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.

artículo científico publicado en 2016

A new approach to obtaining Nα -t-Boc-amino acid aldehydes from asparagine and glutamine for reduced amide pseudopeptide solid-phase synthesis

artículo científico publicado en 2011

A rational strategy for a malarial vaccine development.

artículo científico publicado en 2007

Biological activity of secondary metabolites from Peltostigma guatemalense.

artículo científico publicado en 2009

COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach

artículo científico publicado en 2020

Characterization of a reduced peptide bond analogue of a promiscuous CD4 T cell epitope derived from the Plasmodium falciparum malaria vaccine candidate merozoite surface protein 1.

artículo científico publicado en 2004

Development of designed site-directed pseudopeptide-peptido-mimetic immunogens as novel minimal subunit-vaccine candidates for malaria.

artículo científico publicado en 2010

Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.

artículo científico publicado en 2011

MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.

artículo científico publicado en 2003

Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis.

artículo científico publicado en 2004

Protecting capacity against malaria of chemically defined tetramer forms based on the Plasmodium falciparum apical sushi protein as potential vaccine components.

artículo científico publicado en 2014

Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides

artículo científico publicado en 2005

Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.